X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1321) 1321
Publication (138) 138
Book Review (43) 43
Book Chapter (25) 25
Newsletter (12) 12
Newspaper Article (5) 5
Book / eBook (4) 4
Magazine Article (4) 4
Conference Proceeding (2) 2
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (932) 932
index medicus (836) 836
female (418) 418
male (402) 402
transplantation (391) 391
maintenance (347) 347
immunosuppression (333) 333
maintenance therapy (311) 311
adult (309) 309
immunosuppressive agents - therapeutic use (291) 291
surgery (260) 260
middle aged (259) 259
treatment outcome (258) 258
gastroenterology & hepatology (254) 254
immunology (233) 233
maintenance immunosuppression (199) 199
animals (189) 189
crohn's disease (187) 187
infliximab (178) 178
kidney transplantation (175) 175
immunotherapy (173) 173
therapy (169) 169
inflammatory-bowel-disease (165) 165
mycophenolate-mofetil (157) 157
risk factors (157) 157
inflammatory bowel disease (143) 143
crohns-disease (141) 141
graft rejection - prevention & control (135) 135
aged (131) 131
retrospective studies (131) 131
randomized-trial (130) 130
drug therapy, combination (129) 129
crohn disease - drug therapy (124) 124
azathioprine (122) 122
adolescent (120) 120
antibodies, monoclonal - therapeutic use (118) 118
ulcerative colitis (113) 113
care and treatment (112) 112
induction (112) 112
kidneys (112) 112
pharmacology & pharmacy (110) 110
health aspects (108) 108
time factors (106) 106
immunosuppressive agents - adverse effects (104) 104
recipients (104) 104
research (104) 104
double-blind (103) 103
immunosuppressive agents - administration & dosage (101) 101
kidney-transplantation (99) 99
remission (99) 99
ulcerative-colitis (99) 99
follow-up studies (98) 98
tacrolimus (98) 98
urology & nephrology (96) 96
young adult (94) 94
renal-transplantation (92) 92
patients (89) 89
analysis (88) 88
cyclosporine (87) 87
immunosuppressive agents (87) 87
oncology (86) 86
remission induction (86) 86
child (85) 85
tumor necrosis factor-alpha - antagonists & inhibitors (82) 82
adalimumab (81) 81
graft survival (80) 80
medicine, general & internal (80) 80
efficacy (79) 79
prognosis (75) 75
inflammatory bowel diseases - drug therapy (73) 73
transplants & implants (73) 73
corticosteroids (72) 72
drug therapy (72) 72
graft rejection - immunology (72) 72
cancer (71) 71
review (71) 71
mycophenolic acid - therapeutic use (70) 70
prospective studies (70) 70
article (69) 69
drug administration schedule (67) 67
free maintenance immunosuppression (67) 67
mice (67) 67
mortality (67) 67
calcineurin inhibitors (66) 66
recurrence (66) 66
long-term (65) 65
cyclophosphamide (64) 64
induction therapy (64) 64
gastrointestinal agents - therapeutic use (63) 63
medicine (63) 63
survival (63) 63
graft rejection (62) 62
management (62) 62
mycophenolic acid - analogs & derivatives (62) 62
anti-inflammatory agents - therapeutic use (61) 61
clinical trials (61) 61
organ transplant recipients (60) 60
disease (59) 59
tolerance (59) 59
abridged index medicus (58) 58
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Inflammatory Bowel Diseases, ISSN 1078-0998, 02/2018, Volume 24, Issue 3, pp. 539 - 545
Journal Article
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 58, pp. 98200 - 98214
Although lenalidomide and pomalidomide are well-established treatment options in patients with multiple myeloma, their immune-modulating effects are not fully... 
Regulatory T-cells | Lenalidomide | IL-6 | Multiple myeloma | MULTIPLE-MYELOMA | multiple myeloma | CYCLOPHOSPHAMIDE | NATURAL-KILLER-CELL | PERIPHERAL-BLOOD | CEREBLON | THALIDOMIDE | regulatory T-cells | MAINTENANCE THERAPY | CELL BIOLOGY | CD4(+) CD25(+) | lenalidomide | EXPRESSION | GRANZYME-B
Journal Article
Journal of Thoracic Disease, ISSN 2072-1439, 05/2018, Volume 10, Issue 5, pp. 3141 - 3155
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 10/2005, Volume 5, Issue 10, pp. 2473 - 2478
Journal Article
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 05/2019, Volume 49, Issue 10, pp. 1260 - 1273
Summary Background Calcineurin‐inhibitor immunosuppressants (tacrolimus and ciclosporin) have been associated with an exposure‐related increase in tumour... 
SURVIVAL | MAINTENANCE | MULTICENTER | IMPACT | PHARMACOLOGY & PHARMACY | RECURRENCE | REDUCED TACROLIMUS | RECIPIENTS | INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | MILAN CRITERIA | Tacrolimus | Analysis | Immunotherapy | Liver | Transplantation | Cyclosporine | Hepatoma
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 9/2019, Volume 12, Issue 3, pp. 216 - 221
Immunosuppression (IS) is administered to kidney transplant recipients to prevent rejection episodes and loss of the renal allograft. Most centers rely on a... 
Cytomegalovirus | Medicine & Public Health | Maintenance therapy | Complications | Induction therapy | Oncology | Malignancy | Polyoma virus | Diabetes | Medicine/Public Health, general
Journal Article
Drugs, ISSN 0012-6667, 5/2010, Volume 70, Issue 7, pp. 793 - 804
Journal Article
世界肝病学杂志:英文版(电子版), ISSN 1948-5182, 2015, Volume 7, Issue 10, pp. 1355 - 1368
The optimal level of immunosuppression in solid organtransplantation, in particular for the liver, is a delicatebalance between the benefit of preventing... 
induction | Immunosuppression;Immunosuppression | Immunosuppressionmaintenance | Liver | transplantation | Immunosuppression maintenance | Immunosuppression | Immunosuppression induction | Liver transplantation | Review
Journal Article